Fair Value Measurements
|12 Months Ended|
Dec. 31, 2020
|Fair Value Disclosures [Abstract]|
|Fair Value Measurements||Fair Value Measurements
The following tables present the financial instruments that were measured at fair value on a recurring basis at December 31, 2020 and 2019 by level within the fair value hierarchy (in thousands):
There were no investments in non-marketable debt and equity securities at December 31, 2019.
The fair value of non-marketable securities remeasured due to impairment would be classified within level 3.During the year ended December 31, 2020, we did not recognize any significant other-than-temporary impairment losses. After the adoption of ASU 2016-13, we did not recognize any significant credit losses.
The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef